The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Open accessAbstract
By integrating an agonist satiety signal, provided by alpha-melanocyte-stimulating hormone (alpha-MSH), and an antagonist signal, provided by agouti-related protein (AGRP), the melanocortin-4 receptor (MC4-R) is a key element in the hypothalamic control of food intake. Inactivation of the gene encoding this G protein-coupled receptor causes obesity in mice. In humans, frameshift mutations in MC4-R cause an early-onset dominant form of obesity in two families. In this study we find a high frequency (4%) of rare heterozygous MC4-R mutations in a large population of morbidly obese patients. No such mutations were found in controls. By analyzing the phenotypes of the probands carrying these mutations, we demonstrate that these patients display a common, nonsyndromic form of obesity. Interestingly, functional analysis of the mutant receptors indicates that obesity-associated defects in MC4-R range from loss of function to constitutive activation. Transmission of these mutations in the families of the carriers indicates a variable expressivity that is not related to the functional severity of the mutations. This variable expressivity of MC4-R-associated obesity is not due to variations in genes for alpha-MSH or AGRP. Taken together, these results demonstrate that MC4-R mutations are a frequent but heterogeneous genetic cause of morbid obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of POMC-MC4R signalling causes hyperphagia and is the most common known genetic cause of morbid obesity in children193,194.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
Stunkard, A. J., & Messick, S. (1985) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(85)90010-8 · Cited by 4,687
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Self-citationEnvironmental Contributions to the Obesity Epidemic
Hill, J. O., & Peters, J. C. (1998) · Science · doi:10.1126/science.280.5368.1371 · Cited by 2,258
Flagged first, then by citations
Research works printed but not linked: 1
- Rolland-Cachera, 1991, Eur J Clin Nutr, 45, 13
Cited by
Sorted by citations
Items 401–500 of 901
Overweight Humans Are Resistant to the Weight-Reducing Effects of Melanocortin4–10
Hallschmid, M., Smolnik, R., McGregor, G. P., Jan Born, A., & Fehm, H. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0906 · Cited by 35
Rodrigues, A. R., Almeida, H., & Gouveia, A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.04.008 · Cited by 34
Hu, T., Yang, Z., & Li, M. D. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9800-y · Cited by 34
High Prevalence of Rare Monogenic Forms of Obesity in Obese Guadeloupean Afro-Caribbean Children
Foucan, L., Larifla, L., Durand, E., Rambhojan, C., Armand, C., Michel, C.-T., Billy-Brissac, R., Dhennin, V., Graeve, F. D., Rabearivelo, I., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01956 · Cited by 34
Self-citationGene polymorphisms and their effects in the melanocortin system
Carroll, L. J., Voisey, J., & van Daal, A. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.031 · Cited by 34
Mouse Genetic Approaches to Feeding Regulation: Serotonin 5-HT2CReceptor Mutant Mice
Tecott, L. H., & Abdallah, L. (2003) · CNS Spectrums · doi:10.1017/s109285290001885x · Cited by 36
Emerging treatments for severe obesity in children and adolescents
Coles, N., Birken, C. S., & Hamilton, J. K. (2016) · BMJ · doi:10.1136/bmj.i4116 · Cited by 35
Ciliary dysfunction and obesity
Mok, C. A., Héon, E., & Zhen, M. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01305.x · Cited by 33
Increased constraints on MC4R during primate and human evolution
Hughes, D. A., Hinney, A., Brumm, H., Wermter, A., Biebermann, H., Hebebrand, J., & Stoneking, M. (2008) · Human Genetics · doi:10.1007/s00439-008-0591-8 · Cited by 33
Compartmentalised cAMP signalling in the primary cilium
Paolocci, E., & Zaccolo, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1187134 · Cited by 31
The Val103Ile Polymorphism of Melanocortin‐4 Receptor Regulates Energy Expenditure and Weight Gain
Rutanen, J., Pihlajamäki, J., Karhapää, P., Vauhkonen, I., Kuusisto, J., Mykkänen, L. M., & Laakso, M. (2004) · Obesity Research · doi:10.1038/oby.2004.133 · Cited by 32
A Novel Mutation inLeptinGene Is Associated with Severe Obesity in Chinese Individuals
Zhao, Y., Hong, N., Liu, X., Wu, B., Tang, S., Yang, J., Hu, C., & Jia, W. (2014) · BioMed Research International · doi:10.1155/2014/912052 · Cited by 32
Ho-Urriola, J., Guzmán‐Guzmán, I. P., Smalley, S. V., González, A., Gerardo Weisstaub, N., Domínguez-Vásquez, P., Valladares, M., Amador, P., Hodgson, M. I., Obregón, A. M., et al. (2013) · Nutrition · doi:10.1016/j.nut.2013.05.030 · Cited by 32
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study
Sailors, M. L., Folsom, A. R., Ballantyne, C. M., Hoelscher, D. M., Jackson, A. S., Kao, W. H. L., Pankow, J. S., & Bray, M. S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00637.x · Cited by 32
The Role of Melanocortins in Skin Homeostasis
Böhm, M., & Luger, T. A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053273 · Cited by 32
The 103I Variant of the Melanocortin 4 Receptor Is Associated with Low Serum Triglyceride Levels
Brönner, G., Sattler, A., Hinney, A., Soufi, M., Geller, F., Schäfer, H., Maisch, B., Hebebrand, J., & Schaefer, J. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0919 · Cited by 31
Capel, F. (2007) · CRC Press eBooks · doi:10.3109/9781420020137 · Cited by 31
G protein-coupled receptor (GPCR) gene variants and human genetic disease
Thompson, M. D., Percy, M. E., Cole, D. E. C., Bichet, D. G., Hauser, A. S., & Gorvin, C. M. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2286606 · Cited by 34
Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity
Apalasamy, Y. D., & Mohamed, Z. (2015) · Human Genetics · doi:10.1007/s00439-015-1533-x · Cited by 35
Novel melanocortin 4 receptor gene mutations in severely obese children
Lee, Y. S., Poh, L. K. S., Kek, B. L. K., & Loke, K. Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03071.x · Cited by 30
Drabkin, M., Birk, O. S., & Birk, R. Z. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0654-1 · Cited by 30
A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity
Roth, C. L., Ludwig, M. Z., Woelfle, J., Fan, Z.-C., Brumm, H., Biebermann, H., & Tao, Y. (2009) · Endocrine · doi:10.1007/s12020-009-9156-4 · Cited by 30
Hypothalamic peptides as drug targets for obesity
Dhillo, W. S. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00110-2 · Cited by 30
Editorial: Hypothalamic Melanocortin Signaling in Cachexia
Lechan, R. M., & Tatro, J. B. (2001) · Endocrinology · doi:10.1210/endo.142.8.8408 · Cited by 30
Pillot, B., Duraffourd, C., Bégeot, M., Joly, A., Luquet, S., Houberdon, I., Naville, D., Vigier, M., Gautier-Stein, A., Magnan, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019107 · Cited by 29
Clinical and Functional Relevance of Melanocortin-4 Receptor Variants in Obese German Children
Melchior, C., Schulz, A., Windholz, J., Kieß, W., Schöneberg, T., & Körner, A. (2012) · Hormone Research in Paediatrics · doi:10.1159/000343816 · Cited by 29
Yoshioka, N., Tanaka, M., Ochi, K., Watanabe, A., Ono, K., Sawada, M., Ogi, T., Itoh, M., Ito, A., Shiraki, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111738 · Cited by 30
Obesity Pharmacotherapy: Current Perspectives and Future Directions
Misra, M. (2013) · Current Cardiology Reviews · doi:10.2174/157340313805076322 · Cited by 29
Valli‐Jaakola, K., Palvimo, J. J., Lipsanen‐Nyman, M., Salomaa, V. V., Peltonen, L., KONTULA, K. K., & Schalin‐Jäntti, C. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093469 · Cited by 29
Say, Y.-H. (2017) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-017-0142-x · Cited by 29
Obesity and Diabetes: A Sword of Damocles for Future Generations
Angi, A., & Chiarelli, F. (2020) · Biomedicines · doi:10.3390/biomedicines8110478 · Cited by 30
Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders
Copperi, F., Kim, J. D., & Diano, S. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.026 · Cited by 27
Five‐year outcome of bariatric surgery in a patient with melanocortin‐4 receptor mutation
Elkhenini, H., New, J. P., & Syed, A. A. (2014) · Clinical Obesity · doi:10.1111/cob.12051 · Cited by 28
To eat or not to eat; regulation by the melanocortin system
Hillebrand, J. J., Kas, M. J., & Adan, R. A. H. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.01.034 · Cited by 28
Central nervous system regulation of adipocyte metabolism
Nogueiras, R., Wilson, H., Rohner‐Jeanrenaud, F., & Tschöp, M. H. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.09.034 · Cited by 29
Melanocortin‐4 Receptor Gene Mutations in a Dutch Cohort of Obese Children
van den Berg, L., van Beekum, O., Heutink, P., Felius, B. A., van de Heijning, M. P. M., Strijbis, S., van Spaendonk, R. M. L., Piancatelli, D., Garner, K. M., Aouad, R. E., et al. (2010) · Obesity · doi:10.1038/oby.2010.259 · Cited by 28
Rosa, M. C. D., Chesi, A., McCormack, S. E., Zhou, J., Weaver, B., McDonald, M. C., Christensen, S., Liimatta, K., ROSENBAUM, M. S., Hakonarson, H. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02657 · Cited by 29
Neurotrophins and the Regulation of Energy Balance and Body Weight
Rios, M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_11 · Cited by 28
Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants
Al-Fulaij, M. A., Ren, Y., Beinborn, M., & Kopin, A. S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9030-x · Cited by 28
Leptin Infusion and Obesity in Mouse Cause Alterations in the Hypothalamic Melanocortin System
Gout, J., Sarafian, D., Tirard, J., Blondet, A., Vigier, M., Rajas, F., Mithieux, G., Bégeot, M., & Naville, D. (2008) · Obesity · doi:10.1038/oby.2008.303 · Cited by 28
Emerging trends in the search for genetic variants predisposing to human obesity
Swarbrick, M. M., & Vaisse, C. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078997.96795.03 · Cited by 28
Self-citationBody Weight Regulation by Selective MC4 Receptor Agonists and Antagonists
Foster, A. C., Joppa, M. A., Markison, S., Gogas, K. R., Fleck, B. A., MURPHY, B. J., Wolff, M., Cismowski, M. J., LING, N. C., Goodfellow, V. S., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03168.x · Cited by 28
Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases
Song, J., & Choi, S. (2023) · Experimental Neurobiology · doi:10.5607/en23040 · Cited by 34
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 27
Morens, C., Keijzer, M., de Vries, K., Scheurink, A. J. W., & van Dijk, G. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00774.2004 · Cited by 27
Proneth, B., Xiang, Z., Pogozheva, I. D., Litherland, S. A., Gorbatyuk, O. S., Shaw, A. M., Millard, W. J., Mosberg, H. I., & Haskell‐Luevano, C. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00362.x · Cited by 27
Microarray gene expression profiling in obesity and insulin resistance
Permana, P. A., Parigi, A. D., & Tataranni, P. A. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.023 · Cited by 27
Gillyard, T. R., Fowler, K., Williams, S. Y., & Cone, R. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12795 · Cited by 26
Genetic Findings in Anorexia and Bulimia Nervosa
Hinney, A., Scherag, S., & Hebebrand, J. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-375003-7.00009-1 · Cited by 26
Molecular basis of melanocortin-4 receptor for AGRP inverse agonism
Chen, M., Celik, A., Georgeson, K. E., Harmon, C. M., & Yang, Y. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.04.010 · Cited by 26
Zuo, B., Liu, G., Peng, Y., Qian, H., Liu, J., Jiang, X., & Mara, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3583-x · Cited by 26
Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders
Adan, R. A. H., & Vink, T. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00125-0 · Cited by 26
Adolescent Obesity and Bariatric Surgery
Helmrath, M. A., Brandt, M. L., & Inge, T. H. (2006) · Surgical Clinics of North America · doi:10.1016/j.suc.2005.12.015 · Cited by 25
Lessons in obesity from transgenic animals
Arch, J. R. S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344050 · Cited by 27
Decrease of food intake by MC4-R agonist MTII in Siberian hamsters in long and short photoperiods
Schuhler, S., Horan, T. L., Hastings, M. H., Mercer, J. G., Morgan, P. J., & Ebling, F. J. P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00331.2002 · Cited by 26
Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance
Gavini, C. K., Cook, T. M., Rademacher, D. J., & Mansuy‐Aubert, V. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153990 · Cited by 26
Granell, S., Serra‐Juhé, C., Martos‐Moreno, G. Á., Díaz, F., Jurado, L. A. P., Baldini, G., & Argente, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050894 · Cited by 25
Obici, S., Magrisso, I. J., Ghazarian, A. S., Shirazian, A., Miller, J. R., Loyd, C., Begg, D. P., Carhuatanta, K. A. K., Haas, M. K., Davis, J. F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.003 · Cited by 26
ABDOMINAL OBESITY STUDY GROUP, von Eyben, F. E., Kroustrup, J. P., Larsen, J. F., & Celis, J. E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.063 · Cited by 27
Neuropeptide gene polymorphisms and human behavioural disorders
Inui, A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1252 · Cited by 25
The combined effect of MC4R and FTO risk alleles on childhood obesity in Greece
Lazopoulou, N., Gioka, E., Ντάλλα, Ι., Pervanidou, P., Magiakou, A.-M., Roma‐Giannikou, E., Chrousos, G. P., Papassotiriou, I., Dedoussis, G. V., & Kanaka‐Gantenbein, C. (2014) · HORMONES · doi:10.14310/horm.2002.1524 · Cited by 25
Spradley, F. T., Palei, A. C., & Granger, J. P. (2013) · Physiological Reports · doi:10.1002/phy2.81 · Cited by 25
Faham, M., Zheng, J., Moorhead, M., Fakhrai-Rad, H., Namsaraev, E. A., Wong, K., Wang, Z., Chow, S. G., Lee, L., Suyenaga, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506677102 · Cited by 25
Engineering the Melanocortin‐4 Receptor to Control Gs Signaling in Vivo
SRINIVASAN, S., Vaisse, C., & Conklin, B. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03184.x · Cited by 25
Self-citationAgosti, F., González, S. C., Damonte, V. M., Tolosa, M. J., Siervi, N. D., Schiöth, H. B., Davio, C. A., Perelló, M., & Raingo, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.007 · Cited by 24
Obesidad, tejido adiposo y cirugía bariátrica
Frigolet, M. E., Dong-Hoon, K., Canizales‐Quinteros, S., & Gutiérrez‐Aguilar, R. (2020) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.19000115 · Cited by 34
Cardiometabolic Syndrome: An Update on Available Mouse Models
Aravani, D., Kassi, E. N., Chatzigeorgiou, A., & Vakrou, S. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721388 · Cited by 26
Negrea, M. O., Neamtu, B. M., Dobrotă, I., Șofariu, C. R., Crișan, R.-M., Bacila, C. I., Domnariu, C. D., & Teodoru, M. (2021) · Applied Sciences · doi:10.3390/app112311565 · Cited by 26
Neuronal primary cilia integrate peripheral signals with metabolic drives
DeMars, K. M., Ross, M. R., Starr, A., & McIntyre, J. C. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1150232 · Cited by 21
Monogenic human obesity syndromes
Farooqi, I. S. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)53006-7 · Cited by 24
Semaglutide treatment of hypothalamic obesity – a real-life data study
Svendstrup, M., Rasmussen, A. K., Kistorp, C., Klose, M., & Andreassen, M. (2024) · Pituitary · doi:10.1007/s11102-024-01429-5 · Cited by 23
Adeva‐Andany, M. M., Domínguez-Montero, A., Adeva-Contreras, L., Fernández‐Fernández, C., Carneiro-Freire, N., & González-Lucán, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230816111624 · Cited by 25
for the GenomEUtwin—project, Kettunen, J., Perola, M., Martin, N. G., Cornes, B. K., Wilson, S. G., Montgomery, G. W., Benyamin, B., Harris, J. R., Boomsma, D. I., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.168 · Cited by 23
Thyroid Disorders and Diabetes Mellitus: Double Trouble
Ray, S. (2016) · Journal of Diabetes Research and Therapy · doi:10.16966/2380-5544.113 · Cited by 24
Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity
van Dijk, G., de Vries, K., Benthem, L., Nyakas, C. J., Buwalda, B., & Scheurink, A. J. W. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.090 · Cited by 24
Wilczynski, A. M., Wilson, K. R., Scott, J. W., Edison, A. S., & Haskell‐Luevano, C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049010r · Cited by 23
Morgan, C. M., Tanofsky‐Kraff, M., Wilfley, D. E., & Yanovski, J. A. (2002) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(01)00007-4 · Cited by 23
Discussing the Putative Role of Obesity-Associated Genes in the Etiopathogenesis of Eating Disorders
Gervasini, G., & Gamero‐Villarroel, C. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.77 · Cited by 22
Melanocortin MC4 receptor expression sites and local function
Siljee-Wong, J. E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.104 · Cited by 22
Xiao, Q., Wu, X., Michal, J. J., Reeves, J. J., Busboom, J. R., Thorgaard, G. H., & Jiang, Z. (2006) · International Journal of Biological Sciences · doi:10.7150/ijbs.2.171 · Cited by 23
Segregation Analysis of Overweight Body Condition in an Experimental Cat Population
Häring, T., Wichert, B. A., Dolf, G., & Haase, B. (2011) · Journal of Heredity · doi:10.1093/jhered/esr029 · Cited by 23
Neuropeptide receptors as potential pharmacological targets for obesity
Meneguetti, B. T., Cardoso, M. H. E. S., Ribeiro, C. F. A., Felício, M. R., Pinto, I. B., Santos, N. C., Carvalho, C. M. E., & Franco, O. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.002 · Cited by 23
Beckers, S., Mertens, I. L., Peeters, A. V., Gaal, L. V., & Hul, W. V. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803126 · Cited by 22
Schuhler, S., Horan, T. L., Hastings, M. H., Mercer, J. G., Morgan, P. J., & Ebling, F. J. P. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00260-2 · Cited by 22
Unconventional Wisdom About the Obesity Epidemic Symbol
Zinn, A. R., & Palmer, B. F. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181ccb980 · Cited by 21
Fojas, E. G., Radha, S. K., Ali, T., Nadler, E. P., & Lessan, N. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.792354 · Cited by 21
[Regulation of dietary intake and energy balance: factors and mechanisms involved].
González‐Jiménez, E., & Schmidt‐RioValle, J. (2012) · PubMed · doi:10.3305/nh.2012.27.6.6099 · Cited by 21
Metabolic and melanocortin gene expression alterations in male offspring of obese mice
Gout, J., Sarafian, D., Mutel, E., Vigier, M., Rajas, F., Mithieux, G., Bégeot, M., & Naville, D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.021 · Cited by 21
Replication and Extension of Association Between Common Genetic Variants in SIM1 and Human Adiposity
Swarbrick, M. M., Evans, D. S., Valle, M. I., Favre, H., Wu, S., Njajou, O. T., Li, R., Zmuda, J. M., Miljkovic, I., Harris, T. B., et al. (2011) · Obesity · doi:10.1038/oby.2011.79 · Cited by 21
Self-citationHyperactive Vasopressin Receptors and Disturbed Water Homeostasis
Knoers, N. V. A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058006 · Cited by 21
Barb, C. R., Hausman, G. J., Romdhane Rekaya, A., Lents, C. A., Lkhagvadorj, S., Qu, L., Cai, W., Couture, O. P., Anderson, L. L., Dekkers, J. C. M., et al. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00006.2010 · Cited by 21
Eerola, K., Nordlund, W., Virtanen, S., Dickens, A. M., Mattila, M., Ruohonen, S. T., Chua, S. C., Wardlaw, S. L., Savontaus, M., & Savontaus, E. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12109 · Cited by 21
Takakura, K., Oikawa, T., Tomita, Y., Mizuno, Y., Nakano, M., Saeki, C., Torisu, Y., & Saruta, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i18.1989 · Cited by 21
Prevention and Control of Childhood Obesity: The Backbone in Prevention of Non Communicable Disease
Kelishadi, R., & Heidari‐Beni, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-10616-4_7 · Cited by 24
Nakao, K., Yasoda, A., Ebihara, K., Hosoda, K., & Mukoyama, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0515-7 · Cited by 21
Suviolahti, E., Ridderstråle, M., Almgren, P., Klannemark, M., Melander, O., Carlsson, E., Carlsson, M., Hedenbro, J., & Orho‐Melander, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802392 · Cited by 21
BIOLOGICAL INFLUENCES ON OBESITY
SCHONFELD-WARDEN, N. A., & Warden, C. H. (2001) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70346-1 · Cited by 21
Yang, L., & Tao, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207611 · Cited by 20
Deep Brain Stimulation for Obesity: From a Theoretical Framework to Practical Application
Nangunoori, R., Tomycz, N. D., Oh, M. Y., & Whiting, D. M. (2015) · Neural Plasticity · doi:10.1155/2016/7971460 · Cited by 19
Katsuura‐Kamano, S., Uemura, H., Arisawa, K., Yamaguchi, M., Hamajima, N., Wakai, K., Okada, R., Suzuki, S., Taguchi, N., Kita, Y., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0306-y · Cited by 21
Metadata
- Authors
- Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôtel-Dieu de Paris (FR)
- University of California, San Francisco (US)
- Corresponding author
- Vaisse, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 2000-07-15
- Volume
- 106
- Issue
- 2
- Pages
- 253-262
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC314306
- OpenAlex
- W2118192748
- Cited by
- 897
- References
- 40
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 21 · 2023: 26 · 2022: 18 · 2021: 32 · 2020: 27 · 2019: 28 · 2018: 27 · 2017: 22 · 2016: 26 · 2015: 34 · 2014: 36 · 2013: 22 · 2012: 28
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Danone
- Instituto Danone
- Servier
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Keywords
- melanocortin-4 receptor, MC4R mutations, morbid obesity, agouti-related protein, alpha-melanocyte-stimulating hormone, G protein-coupled receptors, loss of function, constitutive receptor activation, variable expressivity, genetic heterogeneity
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, alpha-MSH, Child, Eating, Female, Genetic Testing, Heterozygote, Humans, Male, Middle Aged, Mutation, Obesity, Morbid, Pedigree, Proteins, Cohort Studies, Frameshift Mutation, Receptors, Corticotropin, Penetrance, Mutation, Missense, Intercellular Signaling Peptides and Proteins, Receptor, Melanocortin, Type 4, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review